Published in Am J Obstet Gynecol on February 01, 2005
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome (2014) 1.35
Metabolic signatures of bacterial vaginosis. MBio (2015) 1.18
Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol (2007) 1.16
Maternal vitamin D status and spontaneous preterm birth by placental histology in the US Collaborative Perinatal Project. Am J Epidemiol (2013) 1.15
Vaginal and oral microbes, host genotype and preterm birth. Med Hypotheses (2009) 0.97
TLR2-mediated cell stimulation in bacterial vaginosis. J Reprod Immunol (2007) 0.95
A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonatal Med (2009) 0.92
Preterm labor and bacterial vaginosis-associated bacteria among urban women. J Perinat Med (2009) 0.87
Difficulty in the management of pregnancy after vaginal radical trachelectomy. Int J Clin Oncol (2012) 0.85
Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health (2014) 0.82
Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population. BMC Pregnancy Childbirth (2014) 0.79
A protocol to identify non-classical risk factors for preterm births: the Brazilian Ribeirão Preto and São Luís prenatal cohort (BRISA). Reprod Health (2014) 0.78
Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy. Metabolomics (2016) 0.78
Sensitive Detection of Thirteen Bacterial Vaginosis-Associated Agents Using Multiplex Polymerase Chain Reaction. Biomed Res Int (2015) 0.78
The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid. PLoS One (2016) 0.77
Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis. Microb Ecol (2014) 0.77
A Comparison of Colorimetric Assessment of Vaginal pH with Nugent Score for the Detection of Bacterial Vaginosis. Infect Dis Obstet Gynecol (2017) 0.75
A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med (2004) 9.62
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86
Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med (2015) 6.12
Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis (2006) 5.82
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11
Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol (2005) 4.61
Fetal pulse oximetry and cesarean delivery. N Engl J Med (2006) 4.45
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18
Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol (2006) 3.87
Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 3.81
Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46
Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol (2008) 3.29
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis (2003) 3.24
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis (2003) 3.20
Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics (2006) 3.16
Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15
The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96
Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol (2009) 2.91
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med (2002) 2.78
The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol (2005) 2.77
Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73
Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol (2006) 2.69
Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol (2006) 2.56
Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension (2009) 2.51
Underreporting of pregnancy-related mortality in the United States and Europe. Obstet Gynecol (2005) 2.41
Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2010) 2.37
Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol (2006) 2.36
Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30
A randomized trial of coached versus uncoached maternal pushing during the second stage of labor. Am J Obstet Gynecol (2006) 2.27